Inflammatory Demyelinating Polyneuropathy Versus Leptomeningeal Disease Following IpilimumabJ Immunother Cancer 6:11, Cafuir, L.,et al, 2018
Neurological Immune-Related Adverse Events of IpilimumabPract Neurol 13:278-280, Bot, I.,et al, 2013